Potential FTC Crackdown Looms Large over Merck’s Potential Seagen Acquisition
The threat of antitrust intervention weighs heavily over reports that Merck is inching closer to its potential acquisition of Seagen. [...]
FDA Gives Amylyx’s ALS Drug a Second Chance
Amylyx’s application for its ALS drug was narrowly shot down by FDA advisors earlier this year because they were not [...]
The Top Line Podcast: 2021 Top 10 List of Pharma Companies by Profit
On the latest episode of The Top Line podcast, Teresa Carey and Querida Anderson talk about Fierce Pharma’s list of [...]
Register for the 2022 STAT Summit by July 22nd to Get 40% Off Your Ticket
This November 15th and 20th, STAT is hosting its 2022 STAT Summit in Boston, Massechusets. The conference is sponsored [...]
Bayer’s Kidney Disease Drug Kerendia Approved in China
Bayer has just earned approval in China for the use of its drug Kerendia (finerenone) in the treatment of chronic [...]
India Fixes Retail Prices of 84 Drug Formulations
India’s National Pharmaceutical Pricing Authority (NPPA) has set the prices of 84 drug formulations, including treatments for diabetes, high cholesterol, [...]
US Govt Signs COVID-19 Vaccine Deal With Pfizer and BioNTech Totalling $3.2 Billion
The US government has signed an agreement to purchase 105 million COVID-19 vaccine doses from Pfizer and BioNTech. The deal [...]
Gilead Reaches $33 M Settlement with Well Care
A $33 million settlement has been reached in Gillead’s 18-month legal battle with Well Care, a healthcare clinic system the [...]
Rising Drug Prices in America and What to Do About Them
Drugmakers have become more brazen in their price hikes in recent decades, with one CEO arguing that spiking the price [...]
Novartis to Lay Off 8,000 Employees
The pharma giant Novartis will lay off up around 8,000 employees in the near future amid internal restructuring efforts. The [...]
New Amsterdam Nets Over $1B for Second Shot at LDL Drug
Amgen’s CETP cholesterol drug Obicetrapib was shelved in 2017 after disappointing results in clinical trials. However, New Amsterdam Pharma has [...]
Webinar – June 29th: Unraveling the Complexities in Nasal Vaccine Development, Manufacturing and Device Selection
Intranasal vaccines represent a novel delivery system that gives drugmakers, providers, and patients additional options to choose from when making [...]
New Data Shows Bristol Meyers Squib’s Zeposia Improves Cognitive Outcomes in Multiple Sclerosis Patients
Results from Bristol Meyers Squib’s (BMS) Phase 3 DAYBREAK and SUNBEAM trials show that Zeposia helps improve and preserve cognitive [...]
Politico Pulse: Addressing Monkeypox Antiviral Shortages
As monkeypox cases continue to spring up across the world, nations are seeking to stock up on the antiviral tecovirimat. [...]
Carbon Bioscience Partners with the Cystic Fibrosis Foundation to Develop New Viral Vector-Based Therapy
Although adeno-associated virus (AAV) gene therapies have represented a large swath of the gene therapeutic landscape for years, they have [...]
FTC puts PBMs and Pharma “On Notice” over Insulin Prices
The US Federal Trade Commission (FTC) has issued a new policy statement saying it will actively target pharmacy benefit managers [...]
ISPOR Publishes HTA Deliberative Process Guidance
ISPOR – The Professional Society for Health Economics and Outcomes Research has published a new guidance on deliberative processes for [...]
Trade and Channel Strategies | December 12-14, 2022 | Philadelphia, PA – Hybrid Event
Advanced therapeutics can’t help patients if they can’t get to patients. At the upcoming Trade & Channel Strategies conference, senior-level [...]
Congressional Democrats Seek DOJ and FTC Investigation into Blood Thinner Price Hikes
Johnson & Johnson and Bristol Meyers Squib are facing increasing scrutiny from members of the US Congress after allegations of [...]
Eli Lilly Gets FDA Approval for First Autoimmune Alopecia Drug
The US Food and Drug Administration (FDA) has approved Eli Lilly’s drug Olumiant for alopecia areata (AA), an autoimmune disorder [...]
FDA Decisions on China-based Trials Speeds Transition to Multiregional Clinical Trials
The US Food and Drug Administration (FDA) has taken an increasingly tough stance on clinical trials performed primarily in China [...]
Study Finds Drug Launch Prices Grew 20% Annually Since 2008
A new study published in JAMA found that launch prices for new drugs have steadily climbed since 2008, with the [...]
Roche’s Vabysmo Could Nab Nearly One Third of Regeneron’s Eylea Patients
Roche’s intraocular injectable Vabysmo has made impressive gains since its approval in January, cranking up the heat on Regeneron’s Eylea. [...]
Whitepaper: Mastering CX for Specialty Care in the Digital Age
The customer experience (CX) is an essential piece of quality specialty care. However, achieving excellent CX requires a carefully planned [...]
BeiGene’s Leukemia Drug FDA Decision Delayed
In a temporary win for AbbVie and Johnson & Johnson’s chronic lymphocytic leukemia (CLL) drug Imbruvica, the FDA has extended [...]